Galactosidase alpha Recombinant Rabbit mAb
Cat No.: ARM1813

Product Name: | Galactosidase alpha Recombinant Rabbit mAb |
Cat No.: | ARM1813 |
source: | Rabbit |
reactivity: | Human |
applications: | WB,IHC,ICC/IF,FC,IP |
clonality: | Monoclonal |
recommended dilution: | WB,IHC,ICC/IF,FC,IP |
format: | Liquid |
isotype: | IgG |
immunogen: | A synthetic peptide of human Galactosidase alpha |
calculated molecular weight: | 49 kDa |
observed molecular weight: | 49 kDa |
genbank accession number: | P06280 |
gene id (ncbi): | 2717 |
purification method: | Affinity Purification |
conjugate: | Un-conjugated |
storage: | Store at -20°C. Supplied in 50nM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
synonyms: | GALA |
category: | Primary Ab |
concentration: | 1mg/ml |
background: | This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties. [provided by RefSeq, Jul 2008] |